Preview

Cardiovascular Therapy and Prevention

Advanced search

Guidance letter for cardiologists of oncology institutions on the prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology

https://doi.org/10.15829/1728-8800-2023-3685

EDN: UOQBUG

About the Authors

Yu. A. Vasyuk
Московский государственный медико-стоматологический университет им. А.И. Евдокимова
Russian Federation


G. E. Gendlin
РНИМУ им. Н.И. Пирогова,
Russian Federation


E. I. Emelina
РНИМУ им. Н.И. Пирогова
Russian Federation


I. G. Nikitin
РНИМУ им. Н.И. Пирогова
Russian Federation


V. I. Potievskaya
Московский научно-исследовательский онкологический институт им. П.А. Герцена — филиал ФГБУ "НМИЦ радиологии" Минздрава России
Russian Federation


E. Yu. Shupenina
Московский государственный медико-стоматологический университет им. А.И. Евдокимова
Russian Federation


References

1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi:10.1093/eurheartj/ehab368.

2. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032. doi:10.1161/CIR.0000000000001063.

3. Lyon AR, López-Fernández T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal. 2022;43(41):4229-361. doi:10.1093/eurheartj/ehac244.

4. Vasyuk YuA, Gendlin GE, Emelina EI, et al. Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy. Russian Journal of Cardiology. 2021;26(9):4703. (In Russ.) doi:10.15829/1560-4071-2021-4703.

5. Larsen CM, Mulvagh SL. Cardio-oncology: what you need to know now for clinical practice and echocardiography. Echo Res Prat. 2017;4(1):33-41. doi:10.1530/ERP-17-0013.

6. Lyon AR, Dent S, Stanway S, et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society. European Journal of Heart Failure. 2020;22(11):1945-60. doi:10.1002/ejhf.1920.

7. Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi:10.15829/1560-4071-2020-4083.


Review

For citations:


Vasyuk Yu.A., Gendlin G.E., Emelina E.I., Nikitin I.G., Potievskaya V.I., Shupenina E.Yu. Guidance letter for cardiologists of oncology institutions on the prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology. Cardiovascular Therapy and Prevention. 2023;22(7):3685. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3685. EDN: UOQBUG

Views: 1702


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)